Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.
Anand Reddi
Anand Reddi | |
|---|---|
| Born | Maryland, USA |
| Nationality | American |
| Education | University of Michigan, Ann Arbor, University of Colorado School of Medicine |
| Occupation(s) | Global Health Policy Specialist, Public Health Advocate, Biotech Executive |
| Known for | Advocacy in global HIV/AIDS treatment and health systems strengthening |
| Awards | Fulbright Scholar, American Medical Association Foundation Leadership Award |
Anand Reddi is a global and public health advocate. Reddi works on health system strengthening initiatives with a focus on global health, implementation science, health financing and public health advocacy.[1][2] A major focus of scholarship is global HIV scale-up including the President's Emergency Plan for AIDS Relief (PEPFAR).[3][4] Since 2014, his focus has shifted to public-private global health partnerships to support access to essential medicines between by the biopharma private sector.[5][6]
- ^ Banning-Lover, Rachel (2017-07-07). "How to make global universal healthcare a reality". The Guardian. ISSN 0261-3077. Retrieved 2024-12-01.
- ^ Liu, Richard (19 November 2020). "Atlantic Dialogues Talks 2020: Health Capacities as a New Power Instrument". The Atlantic Dialogues: Policy Center for the New South.
- ^ October 2011, Ivy Mungcal // 18 (2011-10-18). "Anand Reddi: PEPFAR at Risk Should Mitt Romney Become US President". Devex. Retrieved 2024-11-30.
{{cite web}}: CS1 maint: numeric names: authors list (link) - ^ "The Need For A New AIDS Strategy". Mic. 2011-09-13. Retrieved 2024-12-01.
- ^ Nuki, Paul; Townsley, Simon (18 July 2018). "HIV and Aids in Africa has a new adversary – God and big pharma". The Telegraph.
- ^ Ratcliffe, Rebecca (22 July 2018). "Biker nun on a mission to free Tanzania from grip of HIV". The Guardian.
Previous Page Next Page
